HLA-DR3/4 Heterozygosity is a Risk Factor for Autoantibody Conversion and Type 1 Diabetes Recurrence After Simultaneous Pancreas-Kidney Transplantation

Journal article

Peer reviewed

Stavros Diamantopoulos, Gloria Allende, George W Burke, Gaetano Ciancio and Alberto Pugliese

Clinical immunology (Orlando, Fla.), Vol.123, pp.S22-S22

2007

Metrics

6 Record Views

This output has contributed to the advancement of the following goals:

Source: InCites

Title: HLA-DR3/4 Heterozygosity is a Risk Factor for Autoantibody Conversion and Type 1 Diabetes Recurrence After Simultaneous Pancreas-Kidney Transplantation
Creators: Stavros Diamantopoulos
Gloria Allende
George W Burke
Gaetano Ciancio
Alberto Pugliese
Publication Details: Clinical immunology (Orlando, Fla.), Vol.123, pp.S22-S22
Academic Unit: Miller School of Medicine; Diabetes Research Institute (DRI); Miami Transplant Institute; UMMG Department of Surgery; UMMG Dept of Surgery - Div of Kidney & Pancreas Transplantation
Language: English
Resource Type: Journal article
Record Identifier: 991031600940302976